Progress in Using Circulating Tumor Cell Information to Improve Metastatic Breast Cancer Therapy
Circulating tumor cells (CTCs) were discovered nearly 150 years ago but have only recently been recognized as a feature of most solid tumors due to their extremely low concentration in the peripheral circulation. Several technologies have been developed to isolate and analyze CTCs, which can now be...
Main Authors: | Jose Alemar, Eric R. Schuur |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Journal of Oncology |
Online Access: | http://dx.doi.org/10.1155/2013/702732 |
Similar Items
-
Circulating Tumor Cell Data: Integration with Imaging and Serum Tumor Markers for Metastatic Breast Cancer Patient Management
by: Thomas Marsland, et al.
Published: (2014-03-01) -
Integrating Circulating Tumor Cell Data with Imaging and Serum Prostate-Specific Antigen Measurement for Metastatic Prostate Cancer Therapy Management
by: Oscar Goodman, et al.
Published: (2014-03-01) -
The Role of Circulating Tumor Cells in Chemoresistant Metastatic Breast Cancer
by: Lorena Alexandra Lisencu, et al.
Published: (2021-02-01) -
Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer
by: Giulia Brisotto, et al.
Published: (2020-04-01) -
Can Biomarker Assessment on Circulating Tumor Cells Help Direct Therapy in Metastatic Breast Cancer?
by: Natalie Turner, et al.
Published: (2014-03-01)